Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the August 24, 2015, Federal Register, FDA announced that an applicant for a proposed biosimilar product had notified FDA that a patent infringement action has been filed in connection with the applicant's BLA.
United StatesFood, Drugs, Healthcare, Life Sciences
In the August 24, 2015, Federal
Register, FDA announced that an applicant for a
proposed biosimilar product had notified FDA that a patent
infringement action has been filed in connection with the
applicant's BLA. FDA received notice of the following
complaint: Janssen Biotech, Inc., et. al. v. Celltrion
Healthcare Co., Ltd., et al., 15–cv–10698 (D.
Mass., filed March 6, 2015).
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
